ÂÜÀòÂÒÂ×

Simon Egli is the Chief Commercial Officer at Cytosurge AG since January 2023. Prior to this role, he held the same position at INFORS HT from October 2016 to December 2022. With a background in biotechnology and a strong focus on sales and management, Simon has previously served as the CEO of Infors USA, Inc. and held various sales and management roles at companies such as INFORS HT and Celonic AG. Simon has also pursued executive education, obtaining an International Executive MBA from Rochester-Bern Executive Programs.